These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 12572995

  • 1. ICL670A: preclinical profile.
    Nick H, Wong A, Acklin P, Faller B, Jin Y, Lattmann R, Sergejew T, Hauffe S, Thomas H, Schnebli HP.
    Adv Exp Med Biol; 2002; 509():185-203. PubMed ID: 12572995
    [No Abstract] [Full Text] [Related]

  • 2. Development of tridentate iron chelators: from desferrithiocin to ICL670.
    Nick H, Acklin P, Lattmann R, Buehlmayer P, Hauffe S, Schupp J, Alberti D.
    Curr Med Chem; 2003 Jun; 10(12):1065-76. PubMed ID: 12678677
    [Abstract] [Full Text] [Related]

  • 3. ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture.
    Hershko C, Konijn AM, Nick HP, Breuer W, Cabantchik ZI, Link G.
    Blood; 2001 Feb 15; 97(4):1115-22. PubMed ID: 11159545
    [Abstract] [Full Text] [Related]

  • 4. Deferasirox--an oral agent for chronic iron overload.
    Vanorden HE, Hagemann TM.
    Ann Pharmacother; 2006 Jun 15; 40(6):1110-7. PubMed ID: 16735647
    [Abstract] [Full Text] [Related]

  • 5. Treating iron overload: the state of the art.
    Hershko C.
    Semin Hematol; 2005 Apr 15; 42(2 Suppl 1):S2-4. PubMed ID: 15846582
    [No Abstract] [Full Text] [Related]

  • 6. Clinical pharmacology of deferasirox.
    Tanaka C.
    Clin Pharmacokinet; 2014 Aug 15; 53(8):679-94. PubMed ID: 24996374
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients.
    Allegra S, Cusato J, De Francia S, Pirro E, Massano D, Piga A, D'Avolio A.
    J Pharm Pharmacol; 2017 May 15; 69(5):525-528. PubMed ID: 27230486
    [Abstract] [Full Text] [Related]

  • 9. Exjade (ICL 670): A new oral iron chelator.
    Agarwal MB.
    J Assoc Physicians India; 2006 Mar 15; 54():214-7. PubMed ID: 16800349
    [Abstract] [Full Text] [Related]

  • 10. Do we need more iron-chelating drugs?
    Kontoghiorghes GJ.
    Lancet; 2003 Aug 09; 362(9382):495-6. PubMed ID: 12927446
    [No Abstract] [Full Text] [Related]

  • 11. Preclinical and clinical development of deferitrin, a novel, orally available iron chelator.
    Donovan JM, Plone M, Dagher R, Bree M, Marquis J.
    Ann N Y Acad Sci; 2005 Aug 09; 1054():492-4. PubMed ID: 16339704
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Deferasirox effectively decreases iron burden in patients with double heterozygous HbS/β-thalassemia.
    Voskaridou E, Plata E, Douskou M, Sioni A, Mpoutou E, Christoulas D, Dimopoulou M, Terpos E.
    Ann Hematol; 2011 Jan 09; 90(1):11-5. PubMed ID: 20661572
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, characterization and in vitro anticancer evaluations of two novel derivatives of deferasirox iron chelator.
    Salehi S, Saljooghi ASh, Shiri A.
    Eur J Pharmacol; 2016 Jun 15; 781():209-17. PubMed ID: 27090924
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Deferasirox: A comprehensive drug profile.
    Kabil MF, Nasr M.
    Profiles Drug Subst Excip Relat Methodol; 2024 Jun 15; 49():1-18. PubMed ID: 38423705
    [Abstract] [Full Text] [Related]

  • 18. Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.
    Taher AT, Temraz S, Cappellini MD.
    Expert Rev Hematol; 2013 Oct 15; 6(5):495-509. PubMed ID: 24083402
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thalassemia: cardiac iron and chelators.
    Gaur A.
    Indian Pediatr; 2012 Apr 15; 49(4):268-9. PubMed ID: 22565070
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.